drugset / Trial / NCT01666613
A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different Ways
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to look at drug levels of AZD8683 in blood when the drug is administered in different ways - orally, intravenously or inhaled (with two different devices), to healthy subjects
Timeline
- Start
- 2012-11
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8683 | Unknown | 100 ug | Intravenous |
| Subject | AZD8683 | Unknown | 540 ug | Intravenous |
| Subject | AZD8683 | Unknown | 600 ug | Intravenous |
| Subject | AZD8683 | Unknown | 950 ug | Intravenous |
Indications
No indication recorded.